These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32320045)

  • 1. A New Class of Topical Acne Treatment Addressing the Hormonal Pathogenesis of Acne.
    Barbieri JS
    JAMA Dermatol; 2020 Jun; 156(6):619-620. PubMed ID: 32320045
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical Clascoterone for Acne Vulgaris.
    Burma NE; Woo TE; Parsons L
    Skin Therapy Lett; 2022 Jan; 27(1):1-3. PubMed ID: 35081302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortexolone 17α-propionate 1% cream, a new potent antiandrogen for topical treatment of acne vulgaris. A pilot randomized, double-blind comparative study vs. placebo and tretinoin 0·05% cream.
    Trifu V; Tiplica GS; Naumescu E; Zalupca L; Moro L; Celasco G
    Br J Dermatol; 2011 Jul; 165(1):177-83. PubMed ID: 21428978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clascoterone (Winlevi) for the Treatment of Acne.
    Harris C
    Am Fam Physician; 2021 Jul; 104(1):93-94. PubMed ID: 34264597
    [No Abstract]   [Full Text] [Related]  

  • 5. Clascoterone cream (1%) topical androgen receptor inhibitor for the treatment of acne in patients 12 years and older.
    Gold M
    Expert Rev Clin Immunol; 2021 Apr; 17(4):301-308. PubMed ID: 33616473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clascoterone: a new topical anti-androgen for acne management.
    Santhosh P; George M
    Int J Dermatol; 2021 Dec; 60(12):1561-1565. PubMed ID: 34242398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of hormonal agents in the treatment of acne.
    Hassoun LA; Chahal DS; Sivamani RK; Larsen LN
    Semin Cutan Med Surg; 2016 Jun; 35(2):68-73. PubMed ID: 27416311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Game Changer in Acne Treatment.
    Kircik LH
    J Drugs Dermatol; 2020 Mar; 19(3):28. PubMed ID: 32550698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clascoterone cream (Winlevi) for acne.
    Med Lett Drugs Ther; 2021 Dec; 63(1640):202-204. PubMed ID: 35100239
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy.
    Marks DH; Mansh MD
    JAMA Dermatol; 2020 Dec; 156(12):1380-1381. PubMed ID: 33146681
    [No Abstract]   [Full Text] [Related]  

  • 11. Potential Role for Topical Antiandrogens in the Management of Acne Among Patients Receiving Masculinizing Hormone Therapy-Reply.
    Thiboutot D; Cartwright M; Mazzetti A
    JAMA Dermatol; 2020 Dec; 156(12):1381. PubMed ID: 33146696
    [No Abstract]   [Full Text] [Related]  

  • 12. Clascoterone: First Approval.
    Dhillon S
    Drugs; 2020 Nov; 80(16):1745-1750. PubMed ID: 33030710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult Female Acne: Managing the Hormones.
    Lipson J
    Skin Therapy Lett; 2024 Jul; 29(4):5-7. PubMed ID: 38963912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro.
    Rosette C; Agan FJ; Mazzetti A; Moro L; Gerloni M
    J Drugs Dermatol; 2019 May; 18(5):412-418. PubMed ID: 31141847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clascoterone for treatment of acne.
    Manjaly C; Martinez J; Barbieri J; Mostaghimi A
    Drugs Today (Barc); 2023 Feb; 59(2):71-81. PubMed ID: 36811407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years.
    Piszczatoski CR; Powell J
    Clin Ther; 2021 Oct; 43(10):1638-1644. PubMed ID: 34607697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of topical clascoterone cream for treatment of acne vulgaris: A systematic review and meta-analysis of randomized placebo-controlled trials.
    Alkhodaidi ST; Al Hawsawi KA; Alkhudaidi IT; Magzoub D; Abu-Zaid A
    Dermatol Ther; 2021 Jan; 34(1):e14609. PubMed ID: 33258536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist.
    Kircik LH
    Expert Opin Pharmacother; 2021 Sep; 22(13):1801-1806. PubMed ID: 33906537
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.